Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 13.05
-0.50 (-3.69%)
Jun 25, 2026, 1:30 PM CST
Polaris Group Market Cap
Polaris Group has a market cap or net worth of 11.22 billion as of June 25, 2026. Its market cap has decreased by -64.90% in one year.
Market Cap
11.22B
Enterprise Value
12.45B
Revenue
69.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.05
Market Cap Chart
Since February 15, 2016, Polaris Group's market cap has decreased from 46.46B to 11.22B, a decrease of -75.85%. That is a compound annual growth rate of -12.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 11.22B | -53.17% |
| Dec 31, 2025 | 23.96B | -29.66% |
| Dec 31, 2024 | 34.06B | -39.39% |
| Dec 29, 2023 | 56.21B | -14.57% |
| Dec 30, 2022 | 65.79B | 24.20% |
| Dec 30, 2021 | 52.97B | 373.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiMed Biologics | 17.62B |
| Lumosa Therapeutics | 17.17B |
| Ever Supreme Bio Technology | 15.52B |
| Medigen Vaccine Biologics | 15.16B |
| EirGenix | 14.27B |
| Tanvex BioPharma | 11.99B |
| Locus Cell | 10.46B |
| ACRO Biomedical | 9.19B |